ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,161.08
-0.17%
Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. CytoSorbents Corporation (CTSO)

  7. CytoSorbents Corporation (CTSO) 뉴스

CTSO

CytoSorbents (CTSO)

CytoSorbents Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CTSO
일자시간출처헤드라인심볼기업
2024/05/1006:23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2024/05/1005:17GlobeNewswire Inc.CytoSorbents Reports First Quarter 2024 ResultsNASDAQ:CTSOCytoSorbents Corporation
2024/05/1005:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTSOCytoSorbents Corporation
2024/05/0706:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2024/05/0220:00GlobeNewswire Inc.CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in EuropeNASDAQ:CTSOCytoSorbents Corporation
2024/04/2620:00GlobeNewswire Inc.CytoSorbents to Report First Quarter 2024 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
2024/04/1720:00GlobeNewswire Inc.STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual MeetingNASDAQ:CTSOCytoSorbents Corporation
2024/03/0621:00GlobeNewswire Inc.CytoSorbents to Report Fiscal 2023 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
2024/02/0821:00GlobeNewswire Inc.CytoSorbents to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:CTSOCytoSorbents Corporation
2024/01/1807:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2024/01/1721:15GlobeNewswire Inc.Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant PatientsNASDAQ:CTSOCytoSorbents Corporation
2024/01/0905:00Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CTSOCytoSorbents Corporation
2023/12/2906:49Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2023/12/2821:00GlobeNewswire Inc.CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board RecommendationNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1606:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CTSOCytoSorbents Corporation
2023/12/1323:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2023/12/1323:15GlobeNewswire Inc.CytoSorbents Announces Closing of $10.3 Million Registered Direct OfferingNASDAQ:CTSOCytoSorbents Corporation
2023/12/1206:10Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CTSOCytoSorbents Corporation
2023/12/1206:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2023/11/1006:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CTSOCytoSorbents Corporation
2023/11/1006:15GlobeNewswire Inc.CytoSorbents Reports Third Quarter 2023 Financial and Operational ResultsNASDAQ:CTSOCytoSorbents Corporation
2023/11/1006:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CTSOCytoSorbents Corporation
2023/10/2720:00GlobeNewswire Inc.CytoSorbents to Report Third Quarter 2023 Operating and Financial ResultsNASDAQ:CTSOCytoSorbents Corporation
 검색 관련기사 보기:NASDAQ:CTSO

최근 히스토리

LSE
MEXP
Fmxs&p5-10yracc
BIT
P1SXU3
BNP Paribas Issuance
EU
TUR
Amundi MSCI Turkey UCITS...
LSE
ABTU
USOTC
URPLF
New Klondike Exploration (CE)
EU
F411T
F411T
ASX
NRPHA
National RMBS Trust 2022 1
USOTC
RDEIY
Redeia Corporacion (PK)
TG
DBK
Deutsche Bank
COIN
OSMOBTC
Osmosis
HUOB
JOEUSDT
JoeToken
AMEX
MRW.A
LSE
TRAC
T42 Iot Tracking Solutions
AMEX
HAIL
SPDR S&P Kensho Smart Mo...
BIT
P1SWW1
BNP Paribas Issuance
USOTC
GBCMY
Global Bio Chem Technology (PK)
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유